EUVIMEDEUVIMED entdecken
Crossref

Protective properties of Ophiopogonin D in DSS-induced colitis: insights into microbiota modulation

Tao Zhang, Zhiguo Guo, Xianhui Cheng, Rongmu Xia, Sicong Lai, Lijun Liao

Inflammopharmacology · 2024-10 · 32 (5) · 3553-3570

DOI: 10.1007/s10787-024-01531-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammopharmacology, online erschienen am 22.07.2024. Verfasst von Tao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, 637000, Chin…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Saponins, Spirostans, Dextran Sulfate. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Academic medicine leader's training Program in health systems of Pudong New Area, Shanghai Pudong New Area summit (emergency medicine and critical care) construction project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ulcerative colitis (UC), a chronic inflammatory gastrointestinal disorder, is becoming increasingly prevalent worldwide. Ophiopogonin D, which is derived from Ophiopogon japonicus, exhibits anti-inflammatory and antioxidant properties, yet its therapeutic potential in UC remains unclear. METHODS: In this study, we employed a mouse model of DSS-induced colitis to assess the impact of Ophiopogonin D on various parameters, including weight loss, bloody stools, and inflammation in the colon. RESULTS: Ophiopogonin-D treatment significantly mitigated these DSS-induced effects, improved colon permeability, and modulated inflammatory markers like ZO-1, MUC-2, TNF-α, and IL-1β in mice compared with the control. Furthermore, compared to the DSS-treatment group, Ophiopogonin-D treatment improved the α- and β-diversity indices of the mouse intestinal microbiota, along with an increase in the abundance of genera such as Akkermansia (AKK) and a decrease in the abundance of genera such as Enterobacter. Notably, propionic acid, a metabolite of AKK, demonstrated significant improvement in the symptoms of DSS-induced colitis in mice compared to the control. Moreover, propionic-acid administration also resulted in alterations in the levels of inflammatory factors and calreticulin within the intestinal tissues. CONCLUSION: Overall, Ophiopogonin D significantly affects intestinal microbiota composition, thereby improving symptoms of DSS-induced colitis in mice. These findings present promising therapeutic strategies and potential pharmaceutical candidates for the treatment of ulcerative colitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeSaponinsSpirostansDextran SulfateColitisAnimalsMiceDisease Models, AnimalMaleAnti-Inflammatory AgentsMice, Inbred C57BLColitis, UlcerativeColonInflammation

Stichwörter der Autor:innen

Colitis in miceDSSIntestinal microbiotaOphiopogonin DUlcerative colitis

Substanzen

Saponinsophiopogonin DSpirostansDextran SulfateAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, 637000, China. 305514271@qq.com.
  • Department of Gastroenterology, Suzhou Hospital of Anhui Medical University, Suzhou, 234000, China.
  • School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.
  • Department of Gastroenterology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, No.13 Hudongzhi Road, Gulou District, Fuzhou, 350003, China. xiarongmu@126.com.
  • Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, No.26 Yuancunerheng Road, Tianhe District, Guangzhou, 510000, China. laisc@mail2.sysu.edu.cn.
  • Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510000, China. laisc@mail2.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • the Academic medicine leader's training Program in health systems of Pudong New Area
  • Shanghai Pudong New Area summit (emergency medicine and critical care) construction project
  • Bureau of Science & Technology Nanchong City
  • Shanghai's 2023 "Technology Innovation Action Plan" medical innovation research project
  • Shanghai’s 2023 “Technology Innovation Action Plan” medical innovation research project

Zitieren

APA

Zhang, T., Guo, Z., Cheng, X., Xia, R., Lai, S., & Liao, L. (2024). Protective properties of Ophiopogonin D in DSS-induced colitis: insights into microbiota modulation. Inflammopharmacology, 32(5), 3553-3570. https://doi.org/10.1007/s10787-024-01531-x

Vancouver

Zhang T, Guo Z, Cheng X, Xia R, Lai S, Liao L. Protective properties of Ophiopogonin D in DSS-induced colitis: insights into microbiota modulation. Inflammopharmacology. 2024;32(5):3553-3570. doi:10.1007/s10787-024-01531-x

BibTeX
@article{Zhang2024,
  author = {Zhang, Tao and Guo, Zhiguo and Cheng, Xianhui and Xia, Rongmu and Lai, Sicong and Liao, Lijun},
  title = {Protective properties of Ophiopogonin D in DSS-induced colitis: insights into microbiota modulation},
  journal = {Inflammopharmacology},
  year = {2024},
  volume = {32},
  number = {5},
  pages = {3553--3570},
  doi = {10.1007/s10787-024-01531-x}
}
Kostenlos starten →